BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye Z, Jiang Y, Sun D, Zhong W, Zhao L, Jiang Z. The Plasma Interleukin (IL)-35 Level and Frequency of Circulating IL-35+ Regulatory B Cells are Decreased in a Cohort of Chinese Patients with New-onset Systemic Lupus Erythematosus. Sci Rep 2019;9:13210. [PMID: 31519970 DOI: 10.1038/s41598-019-49748-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Campos GM, Américo MF, Dos Santos Freitas A, Barroso FAL, da Cruz Ferraz Dutra J, Quaresma LS, Cordeiro BF, Laguna JG, de Jesus LCL, Fontes AM, Birbrair A, Santos TM, Azevedo V. Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases. Probiotics Antimicrob Proteins 2023;:1-15. [PMID: 36746838 DOI: 10.1007/s12602-023-10041-1] [Reference Citation Analysis]
2 Zysk W, Gleń J, Trzeciak M. Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis. Int J Mol Sci 2022;23. [PMID: 36555351 DOI: 10.3390/ijms232415709] [Reference Citation Analysis]
3 Xiong H, Tang Z, Xu Y, Shi Z, Guo Z, Liu X, Tan G, Ai X, Guo Q. CD19(+)CD24(high)CD27(+) B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients. Adv Rheumatol 2022;62:48. [PMID: 36494762 DOI: 10.1186/s42358-022-00279-8] [Reference Citation Analysis]
4 Gupta S, Demirdag Y, Gupta AA. Members of the Regulatory Lymphocyte Club in Common Variable Immunodeficiency. Front Immunol 2022;13:864307. [DOI: 10.3389/fimmu.2022.864307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Padhi S, Sarangi S, Nayak N, Barik D, Pati A, Panda AK. Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: A meta and trial sequential analysis. Lupus 2022;:9612033221090172. [PMID: 35353646 DOI: 10.1177/09612033221090172] [Reference Citation Analysis]
6 Xie Y, Zhang H, Huang J, Zhang Q. Interleukin-35 in autoimmune dermatoses: Current concepts. Open Medicine 2022;17:589-600. [DOI: 10.1515/med-2022-0455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ye C, Yano H, Workman CJ, Vignali DAA. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases. J Interferon Cytokine Res 2021;41:391-406. [PMID: 34788131 DOI: 10.1089/jir.2021.0147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jansen K, Cevhertas L, Ma S, Satitsuksanoa P, Akdis M, van de Veen W. Regulatory B cells, A to Z. Allergy 2021;76:2699-715. [PMID: 33544905 DOI: 10.1111/all.14763] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
9 Mohd Shukri ND, Farah Izati A, Wan Ghazali WS, Che Hussin CM, Wong KK. CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients. Front Immunol 2021;12:675250. [PMID: 34149710 DOI: 10.3389/fimmu.2021.675250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Yu B, Wang L, Chu Y. Gut microbiota shape B cell in health and disease settings. J Leukoc Biol 2021;110:271-81. [PMID: 33974295 DOI: 10.1002/JLB.1MR0321-660R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Catalán D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguillón JC, Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol 2021;12:611795. [PMID: 33995344 DOI: 10.3389/fimmu.2021.611795] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
12 Zhu Q, Rui K, Wang S, Tian J. Advances of Regulatory B Cells in Autoimmune Diseases. Front Immunol 2021;12:592914. [PMID: 33936028 DOI: 10.3389/fimmu.2021.592914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hu S, Lian PP, Hu Y, Zhu XY, Jiang SW, Ma Q, Li LY, Yang JF, Yang L, Guo HY, Zhou H, Yang CC, Meng XM, Li J, Li HW, Xu T, Zhou H. The Role of IL-35 in the Pathophysiological Processes of Liver Disease. Front Pharmacol 2020;11:569575. [PMID: 33584256 DOI: 10.3389/fphar.2020.569575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Vincent FB, Figgett WA, Hibbs ML. Hallmark of Systemic Lupus Erythematosus: Role of B Cell Hyperactivity. Pathogenesis of Systemic Lupus Erythematosus 2021. [DOI: 10.1007/978-3-030-85161-3_2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Xie Q, Xu WD, Pan M, Lan YY, Liu XY, Su LC, Huang AF. Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis. Int Immunopharmacol 2021;90:107231. [PMID: 33307515 DOI: 10.1016/j.intimp.2020.107231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang D, Lei L. Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases. Int J Rheum Dis 2021;24:21-7. [PMID: 32918357 DOI: 10.1111/1756-185X.13962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Xing H, Tian G. Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease. BMC Immunol 2020;21:17. [PMID: 32276581 DOI: 10.1186/s12865-020-00348-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Zdanowska N, Owczarczyk-saczonek AB, Zdanowski W, Placek WJ. Interleukin 35: an overview. Pol Ann Med 2020. [DOI: 10.29089/2020.20.00130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]